Breaking News

Coriolis Pharma Partners with Frontier Biosolutions

Coriolis secures investment from KKR to support next steps in growth and to expand global footprint.

Coriolis Pharma, a global service provider and a company involved in formulation R&D for (bio)pharmaceutical drugs, including cell and gene therapy products and vaccines, reported an investment from funds managed by KKR, a global investment firm. Coriolis Pharma will enter into a strategic growth partnership with Frontier Biosolutions, a global pharma services platform newly formed by KKR and Flerie Invest AB. Coriolis Pharma has expertise in formulation research and development, analytic...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters